logo

Quick Facts

Share

Trainline Plc (TRN.L) reported that, in the first four months of fiscal 2023, net ticket sales were up 16% from the same period in pre-COVID fiscal 2020. The Group said this performance reflects a faster than anticipated recovery in rail passenger volume across Europe as well as the benefit increasing...

BiomX Inc. (PHGE) will voluntarily delist its shares of common stock from trading on the Tel Aviv Stock Exchange or the "TASE". The decision is based on a review of the recent trading volume of the company's common stock on the TASE and the costs associated with maintaining a presence on more than one...

Voyager Digital Ltd. (VYGVF.OB, VOYG.TO) said that the company and its main operating subsidiaries filed voluntary petitions for reorganization under Chapter 11 in the U.S. Bankruptcy Court of the Southern District of New York. The company continues to evaluate all strategic alternatives to maximize...

HUTCHMED (China) Limited (HCM), a commercial-stage, biopharmaceutical company, and Inmagene Biopharmaceuticals announced Wednesday that the first participant, based in Australia, was dosed in a global Phase I trial of IMG-007, an investigational OX40 antagonistic monoclonal antibody. The Phase I study...

Genentech, a member of the Roche Group (RHHBY), said Wednesday that the U.S. Food and Drug Administration has accepted the company's Biologics License Application or BLA and granted Priority Review for mosunetuzumab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody, for the treatment...

BioArctic AB's partner Eisai said that the U.S. Food and Drug Administration has accepted the Biologics License Application or BLA under the accelerated approval pathway for lecanemab, an investigational anti-amyloid beta (Aß) protofibril antibody for the treatment of mild cognitive impairment (MCI)...

OBI Pharma, a Taiwan biopharma company, said it has discontinued the phase 1/2 Study for OBI 888, a Globo H antibody. According to the company, preliminary data from phase 1/2 study demonstrated that OBI 888 is a safe and well tolerated product and showed some trends of efficacy. However, due to the...

Nordic Nanovector ASA said it has decided to discontinue PARADIGME, its Phase 2b trial of Betalutin (177Lu lilotomab satetraxetan) in 3rd-line relapsed and anti-CD20 refractory follicular lymphoma or 3L R and R FL. The move comes after a comprehensive review and independent data evaluation of the...

Ascletis Pharma Inc. (ASCLF.PK) said that the Investigational New Drug or IND application of ASC10, an oral inhibitor drug candidate targeting RNA-dependent RNA polymerase (RdRp) for COVID-19, has been filed to the U.S. Food and Drug Administration. But, the IND filing of ASC10 in China is proceeding...

STAG Industrial, Inc. (STAG) Tuesday announced that it has appointed William Crooker as Chief Executive Officer, in addition to his current role as President. The company also appointed Crooker to the Board. As Chief Executive Officer, Crooker will lead and manage the company's business, execute the...

Biotechnology company Novavax, Inc. (NVAX) announced Tuesday that the European Commission (EC) has approved the expanded conditional marketing authorization (CMA) of Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in the European Union (EU) for adolescents aged 12 through 17. The approval follows the positive...

Volvo Group Venture Capital AB announced an investment in Optibus, which develops and provides optimization software for public transportation planning and management. The Optibus solution is in use in 1,000 cities in 26 countries across North and South America, EMEA, and Asia Pacific. "The collaboration...

Amylyx Pharmaceuticals, Inc. (AMLX) announced the FDA is planning to reconvene the Peripheral and Central Nervous System Drugs Advisory Committee to discuss the New Drug Application for AMX0035 for the treatment of amyotrophic lateral sclerosis on September 7, 2022. The PDUFA target action date for the...

Syros Pharmaceuticals (SYRS) and TYME Technologies, Inc. (TYME) announced that the companies have entered into a definitive merger agreement pursuant to which Syros will acquire TYME, including its pipeline assets and net cash at closing which after accounting for wind-down and transaction expenses is...

Xerox has acquired Go Inspire, a UK-based print and digital marketing and communication services provider. Go Inspire serves customers throughout Europe, the Middle East and Africa. Terms of the deal were not disclosed. Xerox said the acquisition supports the company's commitment to expand its Digital...

Follow RTT